NYSE - Nasdaq Real Time Price USD

Avantor, Inc. (AVTR)

Compare
25.54 -0.10 (-0.39%)
At close: September 6 at 4:00 PM EDT
26.18 +0.64 (+2.50%)
After hours: September 6 at 7:25 PM EDT
Loading Chart for AVTR
DELL
  • Previous Close 25.64
  • Open 25.69
  • Bid 25.46 x 1100
  • Ask 25.46 x 1800
  • Day's Range 25.06 - 26.20
  • 52 Week Range 16.63 - 28.00
  • Volume 5,127,881
  • Avg. Volume 8,724,312
  • Market Cap (intraday) 17.363B
  • Beta (5Y Monthly) 1.33
  • PE Ratio (TTM) 49.12
  • EPS (TTM) 0.52
  • Earnings Date Oct 25, 2024 - Oct 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 27.79

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

www.avantorsciences.com

14,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AVTR

View More

Performance Overview: AVTR

Trailing total returns as of 9/6/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AVTR
11.87%
S&P 500
13.39%

1-Year Return

AVTR
21.33%
S&P 500
20.27%

3-Year Return

AVTR
37.28%
S&P 500
19.25%

5-Year Return

AVTR
48.66%
S&P 500
81.73%

Compare To: AVTR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AVTR

View More

Valuation Measures

Annual
As of 9/6/2024
  • Market Cap

    17.36B

  • Enterprise Value

    22.21B

  • Trailing P/E

    49.12

  • Forward P/E

    20.75

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.55

  • Price/Book (mrq)

    3.19

  • Enterprise Value/Revenue

    3.25

  • Enterprise Value/EBITDA

    19.92

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.28%

  • Return on Assets (ttm)

    3.67%

  • Return on Equity (ttm)

    6.90%

  • Revenue (ttm)

    6.83B

  • Net Income Avi to Common (ttm)

    360.2M

  • Diluted EPS (ttm)

    0.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    287.5M

  • Total Debt/Equity (mrq)

    94.11%

  • Levered Free Cash Flow (ttm)

    708.61M

Research Analysis: AVTR

View More

Company Insights: AVTR

Research Reports: AVTR

View More

People Also Watch